Effect and safety of low dose of mycophenolate mofetil and n-acetyl cysteine in interstitial lung disease (ild)
Background: In Interstitial lung disease (ILD), Glucocorticoids and immune-modulatory agents are mainstays of therapy. Only few studies with dose of 2-3 gm. /day have been performed for evaluation of role of Mycophenolate mofetil and N-acetyl-cysteine in ILD(IPF). Aims & objectives: In this study our objective were to examine the safety and efficacy of low dose Mycophenolate Mofetil (MMF) and N-Acetyl cysteine and to determine its impact on lung function in patients with ILD(IPF) based on the ILD subtypes.